While acknowledging the strengths of the study, such as participant criteria, low drop-out rates and high adherence, the researchers also acknowledged limitations, including the relatively short intervention duration and the absence of a third intervention group receiving synbiotics alongside a placebo
The manufacturer can prove, with clinical data, that the medication remains safe and effective through that date
The drug seemed to be a better option
GLP-1 Pipeline Update: November 2024 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Clinical Pharmacist, Drug Information Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Director, Pipeline Lisa Schweizer, PharmD, JD Director, Clinical Program Management Deputy Editor DISCLAIMER The drug pipeline is fluid
All laboratory measurements were performed in accordance with manufacturer instructions and internal quality control procedures
Brunner said overdosing also occurs with the brand-name versions of the drugs and is not limited to compounded medications